Back to search

United Kingdom· GB-APID-13142411000001100

Aciclovir 250mg powder for solution for infusion vials

A aciclovir product containing aciclovir, registered in United Kingdom by Wockhardt UK Ltd. The same ATC class is registered in 17 of our 19 countries.

ATC J05AB01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedAciclovir 250mg powder for solution f…ATCJ05AB01REGISTER NO.GB-APID-1314241100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Aciclovir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AB01 (aciclovir), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Aciclovir · ATC J05AB01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aciclovir costs, country by country.

Normalised to the WHO defined daily dose (4 g), the median price runs from $4.07 in Italy to $13.83 in Switzerland — a ×3.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Aciclovir · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$13.83
  • IT Italy$4.07
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Aciclovir
Manufacturer
Wockhardt UK Ltd
Country
United Kingdom (GB)
ATC code
J05AB01
ATC class
Aciclovir
Defined daily dose
4 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5012727905259

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

560 interactions on record for aciclovir.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aciclovir · interactions on record

560 records

  • 19 severe
  • 27 moderate
  • 7 minor
  • 505 info

Most severe, free to view

  • CidofovirJ05AB12severe
  • TemsirolimusL01EG01severe
  • EverolimusL01EG02severe
  • SirolimusL01EG04severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aciclobene, Aciclostad
  • Belgium · Aciclovir Ab, Aciclovir Agepha
  • Bulgaria · Ацик, Ацикловир Абр
  • Cyprus · Aciclovir Accord, Aciclovir Noridem
  • Czechia · Aciclovir Accord, Aciclovir Noridem
  • Germany · Acic, Acic Creme Bei Lippenherpes
  • Denmark · Aciclodan, Aciclovir 1a Farma
  • Estonia · Acic, Aciclovir Accord
  • Spain · Aciclovir Accord, Aciclovir Altan
  • Finland · Aciclovir Accord, Aciclovir Noridem
  • France · Aciclovir Accord, Aciclovir Agepha
  • Greece · Aciclovir Vocate, Cevinolon
  • Croatia · Aciklovir Accord, Aciklovir Alpha-Medical
  • Hungary · Aciclovir Agepha, Aciclovir Al
  • Ireland · Acic, Acic Cold Sore
  • Iceland · Aciclovir Accord, Aciclovir Alvogen
  • Italy · Aciclin, Aciclinlabiale
  • Lithuania · Acic, Aciclovir Accord
  • Luxembourg · Aciclovir, Aciclovir Eg
  • Latvia · Acic, Aciclovir Accord Healthcare
  • Malta · Medovir, Uniplex
  • Netherlands · Aciclovir Accord, Aciclovir Agepha
  • Norway · Aciclovir Accord, Aciclovir Noridem
  • Poland · Aciclovir Accord, Aciclovir Altan
  • Portugal · Aciclosina, Aciclovax - Iv
  • Romania · Acevirex, Aciclovir
  • Sweden · Aciclovir Accord, Aciclovir Noridem
  • Slovenia · Aciclovir Noridem, Aciklovir Accord
  • Slovakia · Aciclovir Noridem, Aciclovir Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1e286a0b-e18e-4fa3-88e1-e8003019c66d
GET /v1/drugs/1e286a0b-e18e-4fa3-88e1-e8003019c66d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "13142411000001100",
  "desc": "Aciclovir 250mg powder for solution for infusion vials (Wockhardt UK Ltd)",
  "form": "Powder for solution for infusion",
  "vpid": "41485411000001109",
  "source": "dmd",
  "vtm_id": "774425008",
  "strength": "250 mg",
  "substance": "Aciclovir",
  "ingredient": "Aciclovir sodium",
  "supplier_code": "9301611000001105"
}

See everything about aciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.